Lv1
50 积分 2024-08-23 加入
Distal myasthenia gravis
3小时前
已关闭
Clinical characteristics and prognosis of very late-onset myasthenia gravis in China
5个月前
已完结
Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets
5个月前
已完结
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
8个月前
已完结
皖公网安备34019202002308
